107. Juvenile idiopathic arthritis Clinical trials / Disease details


Clinical trials : 441 Drugs : 282 - (DrugBank : 56) / Drug target genes : 52 - Drug target pathways : 142

  
4 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01544114
(ClinicalTrials.gov)
April 201221/2/2012A Safety Study of VIMOVO in Adolescents With Juvenile Idiopathic Arthritis (JIA)A 6-month, Multicenter, Open-label, Safety Study of VIMOVO (250 mg/20 mg, 375 mg/20 mg, and 500 mg/20 mg Naproxen/Esomeprazole) in Adolescents Aged 12 to 16 Years, Inclusive, With Juvenile Idiopathic Arthritis (JIA)Juvenile Idiopathic Arthritis (JIA)Drug: VIMOVO 250/20;Drug: VIMOVO 375/20;Drug: VIMOVO 500/20Horizon Pharma Ireland, Ltd., Dublin IrelandNULLCompleted12 Years16 YearsAll46Phase 4United States
2NCT01358383
(ClinicalTrials.gov)
May 201116/5/2011Assessment of Pharmacokinetics of a Single Oral Dose of VIMOVO in Healthy Adult VolunteersA Phase I, Open-label, Single-center Study to Assess the Pharmacokinetics of a Single Oral Dose of VIMOVO (250 mg Naproxen/20 mg Esomeprazole)in Healthy Adult SubjectsJuvenile Idiopathic ArthritisDrug: naproxen;Drug: esomeprazoleAstraZenecaNULLCompleted18 Years55 YearsBoth28Phase 1United States
3NCT00807846
(ClinicalTrials.gov)
September 200910/12/2008A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric SubjectsA Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.Arthritis, Juvenile RheumatoidDrug: Celecoxib;Drug: NaproxenPfizer's Upjohn has merged with Mylan to form Viatris Inc.NULLCompleted2 Years17 YearsAll201Phase 4United States;Chile;Costa Rica;Peru;Philippines;Russian Federation;Serbia;South Africa;Switzerland;Ukraine
4EUCTR2014-003737-26-Outside-EU/EEA
(EUCTR)
07/04/2015A Phase 4, 6-week, randomized double-blind, multicenter, active-controlled trial to evaluate the effects of Celecoxib (Celebrex®) or Naproxen on blood pressure in paediatric subjects with juvenile idiopathic arthritisA Phase 4, 6-week, randomized double-blind, multicenter, active-controlled trial to evaluate the effects of Celecoxib (Celebrex®) or Naproxen on blood pressure in paediatric subjects with juvenile idiopathic arthritis Juvenile idiopathic arthritis;Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]Trade Name: Celebrex
INN or Proposed INN: Celecoxib
Other descriptive name: CELECOXIB
INN or Proposed INN: Celecoxib
Other descriptive name: CELECOXIB
Product Name: Naproxen
INN or Proposed INN: NAPROXEN SODIUM
Pfizer IncNULLNAFemale: yes
Male: yes
201Phase 4South Africa;Ukraine;United States;Chile;Costa Rica;Peru;Philippines;Russian Federation;Serbia